Merus BV

Company Profile

Merus BV had its IPO on 2016-05-19 under the ticker symbol MRUS.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Merus BV has a staff strength of 0 employees.

Stock update

Shares of Merus BV opened at $20.53 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $19.61 - $21.26, and closed at $20.38.

This is a -0.59% slip from the previous day's closing price.

A total volume of 149,257 shares were traded at the close of the day’s session.

In the last one week, shares of Merus BV have slipped by -15.08%.

Merus BV's Key Ratios

Merus BV has a market cap of $0.918 billion, indicating a price to book ratio of 2.993 and a price to sales ratio of 17.41.

In the last 12-months Merus BV’s revenue was $0.053 billion with a gross profit of $-0.049 billion and an EBITDA of $-0.102 billion. The EBITDA ratio measures Merus BV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Merus BV’s operating margin was -196.5% while its return on assets stood at -15.7% with a return of equity of -19.8%.

In Q2, Merus BV’s quarterly earnings growth was a positive 0% while revenue growth was a positive 2.5%.

Merus BV’s PE and PEG Ratio

Forward PE

-

Trailing PE

-

PEG

0

Its diluted EPS in the last 12-months stands at $-1.867 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Merus BV’s profitability.

Merus BV stock is trading at a EV to sales ratio of 11.67 and a EV to EBITDA ratio of -6.02. Its price to sales ratio in the trailing 12-months stood at 17.41.

Merus BV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Merus BV ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Merus BV ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Merus BV’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Merus BV's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Merus BV paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$20.38

52-Week High

$33.09

52-Week Low

$13.46

Analyst Target Price

$42.3

Merus BV stock is currently trading at $20.38 per share. It touched a 52-week high of $33.09 and a 52-week low of $33.09. Analysts tracking the stock have a 12-month average target price of $42.3.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.